Disparities Between International Guidelines (AHA/ESC/ESVS/ESVM/SVS) Concerning Lower Extremity Arterial Disease: Consensus of the French Society of Vascular Medicine (SFMV) and the French Society for Vascular and Endovascular Surgery (SCVE)

Ann Vasc Surg. 2021 Apr:72:1-56. doi: 10.1016/j.avsg.2020.11.011. Epub 2020 Dec 24.

Abstract

Several international guidelines concerning lower extremity arterial disease (LEAD) have been published recently, in particular, by the American Heart Association the European Society of Cardiology/European Society for Vascular Surgery, the European Society for Vascular Medicine and the Society for Vascular Surgery. These guidelines differ in some respects and certain issues are not addressed. The objective of this consensus driven by the French Societies of vascular Medicine and surgery was to analyze the disparities between the different guidelines, as well as certain issues not covered, and develop proposals with regard to these points. The following fields of LEAD have been explored: 1) classifications, 2) clinical evaluation, 3) diagnostic criteria, 4) quantification of arterial stenosis using duplex ultrasound, 5) detection of asymptomatic multisite lesions, 6) screening for LEAD in the context of cardiac disease, 7) medical treatment, 8) supervised exercise therapy, 9) revascularization and revascularization of the internal artery stenosis, 10) management of chronic limb ischemia, 11) longitudinal follow-up, and 12) diet.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use*
  • Consensus
  • Delphi Technique
  • Diet, Healthy
  • Endovascular Procedures / adverse effects
  • Endovascular Procedures / standards*
  • Evidence-Based Medicine / standards
  • Exercise Therapy / adverse effects
  • Exercise Therapy / standards*
  • Healthcare Disparities*
  • Humans
  • Lower Extremity / blood supply*
  • Peripheral Arterial Disease / diagnostic imaging
  • Peripheral Arterial Disease / therapy*
  • Risk Reduction Behavior
  • Societies, Medical
  • Treatment Outcome
  • Vascular Surgical Procedures / adverse effects
  • Vascular Surgical Procedures / standards*

Substances

  • Cardiovascular Agents